Representative before the EPO

Employment test 11 - 50 employees
Company dna elkington and fife llp
operating since 1927
Headquarter in London and 3 offices
active in Legal Services and IP Consulting

Representative before the EPO

Company dna schlich
no operation time available
850.37
2 offices
active in Legal Services

Representative before the EPO

Company dna palmer biggs patents limited
no operation time available
4 offices
active in Legal Services

Representative before the EPO

Company dna m r hutchins and co ltd
no operation time available
Headquarter in Tunbridge Wells and 2 offices
active in Legal Services

We have observed 29 EP applications Michael Richard Hutchins has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 17, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12770238

COMPOUNDS FOR USE IN CANCER THERAPY

IPC classification:
A61K 31/515, A61P 35/00
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION IN PROGRESS
EP12845964

METHODS, FORMULATIONS, AND KITS FOR RAPIDLY REPLETING FOLATE LEVELS IN WOMEN

IPC classification:
A61K 31/519, C07D 475/04
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP12791446

SUBSTITUTED BENZYLAMINE COMPOUNDS, THEIR USE IN MEDICINE, AND IN PARTICULAR THE TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTION

IPC classification:
A61K 31/44, A61K 31/4164, A61K 31/415, A61K 31/137, C07D 309/14, C07D 305/08, C07D 305/06, C07D 295/02, C07D 233/64, C07D 233/24, C07D 231/12, C07D 213/75, C07D 209/14, C07C 217/58, A61P 31/12
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12810111

PHARMACEUTICALLY ACTIVE PYRAZINE DERIVATIVES

IPC classification:
A61K 31/497, A61K 31/4965, C07D 413/12, C07D 403/12, C07D 241/26, C07D 241/12, A61P 35/00
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13702642

AURORA AND FLT3 KINASES MODULATORS

IPC classification:
A61K 31/496, C07D 413/14, A61P 35/00
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13703308

4,6-SUBSTITUTED 2,5-DIDEOXYSTREPTAMINE AMINOGLYCOSIDE ANTIBIOTICS

IPC classification:
C07H 15/234
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13725184

APPARATUS FOR INVENTORY CONTROL

IPC classification:
G07F 13/04, G07F 13/02, G07F 9/02, G07F 5/26
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION IN PROGRESS
EP13811606

BACTERIAL ENGINEERING

IPC classification:
C12N 15/10
Agent:
Michael Richard Hutchins, Schlich LLP
Agent:
EIP Europe LLP
Status:
EXAMINATION IN PROGRESS
EP14754200

TRICYCLIC HETEROCYCLES AS ANTICANCER AGENTS

IPC classification:
A61K 31/542
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15179511

A MOUNT FOR A LAPTOP COMPUTER

IPC classification:
H04M 1/04, G06F 1/16, F16M 13/00, E05B 73/00, A47F 7/024, F16M 11/04
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
APPLICATION PUBLISHED
EP16150956

TYK2 KINASE INHIBITORS

IPC classification:
A61K 31/422, A61K 31/421, A61P 37/06, A61P 17/06, A61P 29/00, C07D 263/48, C07D 413/12
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP14841419

AN APPARATUS FOR REMOVING IMPURITIES FROM A FLUID STREAM

IPC classification:
B04B 11/06, B04B 11/02, B04B 9/06, B04B 1/00, B04B 5/10
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15746362

PHARMACEUTICAL COMPOUNDS

IPC classification:
C07D 403/12, A61K 31/497, A61K 31/4965
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15712746

SULFONAMIDES DERIVED FROM TRICYCLYL-2-AMINOCYCLOALKANOLS AS ANTICANCER AGENTS

IPC classification:
A61P 37/00, A61P 3/10, A61P 35/00, A61K 31/437, A61K 31/407, A61K 31/519, A61K 31/551, A61K 31/404, A61K 31/553, A61K 31/538, C07D 209/86, C07D 495/04, C07D 267/18, C07D 265/38, C07D 471/04, C07C 311/29, C07D 243/38
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
The patent has been granted
EP15712745

CONSTRAINED TRICYCLIC SULFONAMIDES

IPC classification:
A61P 25/00, A61P 33/00, A61P 31/12, A61P 17/10, A61P 37/00, A61P 3/10, A61P 35/00, C07D 279/36, C07C 311/29, C07D 223/32, C07D 223/28, A61K 31/55, A61K 31/5415, A61K 31/18, C07D 223/26
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15717224

PHARMACEUTICAL FORMULATION COMPRISING A SUBSTITUED PHENYL- (1, 3-DIHYDRO-ISOINDOL-2-YL) -METHANONE

IPC classification:
A61P 35/00, A61K 47/12, A61K 47/02, A61K 31/496
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15783771

MATRIX-FREE POLYMER NANOCOMPOSITES AND RELATED PRODUCTS AND METHODS THEREOF

IPC classification:
C08G 79/02
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15738106

OSTOMY BAG

IPC classification:
A61F 5/445
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15823730

METHOD FOR SCREENING FOR BIOACTIVE NATURAL PRODUCTS

IPC classification:
C12M 1/12, C12N 15/10
Agent:
Michael Richard Hutchins, Schlich LLP
Agent:
EIP Europe LLP
Status:
Request for examination was made
EP16704259

MODULATORS OF THE P70S6 KINASE FOR USE IN THE TREATMENT OF BRAIN DISORDERS AND TRIPLE-NEGATIVE BREAST CANCER

IPC classification:
A61P 25/00, A61P 35/00, A61K 31/53, A61K 31/498, C07D 403/04
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
Request for examination was made
EP17196121

AGENT FOR USE IN THE CASE OF INTESTINAL FRUCTOSE INTOLERANCE

IPC classification:
A23L 29/00, A23L 33/20, A23L 33/18, A23L 33/10, A61K 9/48, A61P 1/00, A61K 38/44
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
Request for examination was made
EP17200433

METHOD AND SYSTEM FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH NEBULIZED ANTICHOLINERGIC ADMINISTRATIONS

IPC classification:
A61P 11/00, A61K 45/06, A61K 31/40, A61K 9/00, A61K 31/56
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
The application has been published
EP17195181

AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE

IPC classification:
A61K 9/48, C12N 9/00, A23L 3/00, A61K 38/46
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
The application has been published
EP16766454

HETEROCYCLIC CONSTRAINED TRICYCLIC SULFONAMIDES AS ANTI-CANCER AGENTS

IPC classification:
A61P 35/00, A61P 25/28, C07D 498/04, C07D 413/04, C07D 403/04, C07D 401/04, C07D 413/14
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
Request for examination was made
EP16766784

HETEROCYCLIC CONSTRAINED TRICYCLIC SULFONAMIDES AS ANTI-CANCER AGENTS

IPC classification:
A61P 35/00, A61P 25/28, A61K 31/55, A61K 31/5415, C07D 417/04, C07D 405/04, C07D 401/04, C07D 401/14
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
Request for examination was made
EP16778295

2-AMINOQUINAZOLINE DERIVATIVES AS P70S6 KINASE INHIBITORS

IPC classification:
A61P 35/00, A61P 25/28, A61K 31/519, C07D 403/04
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
Request for examination was made
EP16750181

AN APPARATUS FOR GENERATING HYDROGEN

IPC classification:
C01B 3/06, C01B 3/08
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
Request for examination was made
EP16788794

BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS

IPC classification:
A61P 35/00, A61K 31/4035, C07D 471/08, C07D 471/04, C07D 417/14, C07D 409/14, C07D 403/14, C07D 413/14, C07D 405/14, C07D 401/14
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
Request for examination was made
EP16860856

FUROSTAN-3-OL DERIVATIVES AS SKELETAL MUSCLE HYPERTROPHIC AGENTS

IPC classification:
A61K 31/58
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
Request for examination was made

Please Sign in to use this feature